Patricia Barrineau
Family · Manning, SCNPI 1184928749
Payments from drug & device makers
Across 53 payments — averaging $17.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$122
- Exact Sciences$90
- GSK$84
- Boehringer Ingelheim$82
- AbbVie$78
- AstraZeneca$63
- plus $424 from 15 others
What the payments were for
- Food & beverage$941100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 8 | $122 |
| Exact Sciences | 5 | $90 |
| GSK | 5 | $84 |
| Boehringer Ingelheim | 4 | $82 |
| AbbVie | 4 | $78 |
| AstraZeneca | 4 | $63 |
| Astellas Pharma US Inc | 3 | $62 |
| Dexcom, Inc. | 2 | $55 |
| Phathom Pharmaceuticals, Inc. | 3 | $43 |
| Amgen | 2 | $39 |
| Merck | 3 | $36 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Phadia US Inc. | 1 | $23 |
| Verity Pharmaceuticals Inc. | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Novartis | 1 | $17 |
| Bayer | 1 | $16 |
| Pfizer | 1 | $16 |
| Medtronic | 1 | $15 |
| Shield Therapeutics Inc | 1 | $15 |
How this compares
$941 in reported general payments places this provider in the 65th percentile of 3,248 family providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 128 | $162,652 |
| JardianceEmpagliflozin | 120 | $157,235 |
| EliquisApixaban | 102 | $91,067 |
| JanuviaSitagliptin Phosphate | 50 | $69,419 |
| MounjaroTirzepatide | 53 | $62,238 |
| TrulicityDulaglutide | 49 | $59,880 |
| XareltoRivaroxaban | 36 | $41,903 |
| FarxigaDapagliflozin Propanediol | 42 | $36,741 |
| RybelsusSemaglutide | 29 | $35,787 |
| JanumetSitagliptin Phos/Metformin Hcl | 39 | $32,206 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 33 | $30,552 |
| Tresiba Flextouch U-200Insulin Degludec | 17 | $29,935 |
| LinzessLinaclotide | 33 | $29,800 |
| Tresiba Flextouch U-100Insulin Degludec | 52 | $28,024 |
| EntrestoSacubitril/Valsartan | 17 | $26,167 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $122 | $198,440157 claims |
| Boehringer IngelheimJardiance | $82 | $157,235120 claims |
| MerckJanuvia, Janumet, Janumet Xr | $36 | $120,033105 claims |
| PfizerEliquis | $16 | $91,067102 claims |
| AstraZenecaFarxiga, Symbicort | $63 | $51,29078 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $84 | $47,65657 claims |
| AbbVieLinzess | $78 | $29,80033 claims |
| NovartisEntresto | $17 | $26,16717 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,248 family providers in South Carolina.
Other family in Manning
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.